LL'S MAGNETIC CLAY INC Recall: The recalled dietary supplement has the potential to contain undeclared allergens, including almonds, shellfish, milk, eggs, and peanuts.

🇺🇸 United States

1. June 29, 2018 - Recall initiated
2. August 8, 2018 - Reported by source
3. February 8, 2019 - Recall terminated

Official source record

Agency

FDA

Dataset

FDA Food Enforcement (Recalls)

Recall number

F-1675-2018

Event ID

80419

Status

Terminated

Classification

Class I

Company

LL'S MAGNETIC CLAY INC

Product description

Prescript-Assist Broad Spectrum Probiotic & Prebiotic Gastrointestinal Support Dietary Supplement, 60-capsule or 90-capsule bottles; UPC Codes: 853956003157, 853956003539

Quantity

290,000 units

Reason

The recalled dietary supplement has the potential to contain undeclared allergens, including almonds, shellfish, milk, eggs, and peanuts.

Recall initiation date

June 29, 2018

Report date

August 8, 2018

Classification date

Not published in this source record

Termination date

February 8, 2019

Distribution pattern

Nationwide throughout the United States and United Kingdom, Mexico, Netherlands, Sweden, Australia, Canada, Hong Kong, Spain, New Zealand, Chile, Taiwan, Switzerland, Albania, Poland, Israel, Monaco, Japan, India, Hungary, Saudi Arabia, Malaysia, UAE, Norway, France, Russia, Australia, Colombia, Czech Republic, Nigeria, Ireland, Philippines

UPC, lot, and code information

All Lots within expiry; Lot # s: 1356300 (exp. 01/2019), 1405700 (exp. 03/2019), 17A128 (exp. 03/2021), W00103 (exp. 06/2019), 16A071, 17A130, 16C076, 15D081, W00095, 15K016, W0135, 15D007, 15D080, 16B174, 16A078, 16D065, 16B041, W0176, 15D115, 16A214.

Voluntary or mandated

Voluntary: Firm initiated

Initial notification method

Press Release

Source last updated

Not tracked separately from the Public Health Trace retrieval date below

Public Health Trace retrieval date

July 18, 2026 ET

Responsible company: LL'S MAGNETIC CLAY INC

Where this information comes from

View FDA enforcement record -- the specific openFDA record this summary was built from.

No separate FDA public notice was found for this enforcement record. The information below comes from FDA's Recall Enterprise System through openFDA.

FDA Enforcement Reports -- FDA's general, official recall and enforcement information.

Technical source data

View raw source data -- the machine-readable record this page's information was built from.

Retrieved by Public Health Trace: July 18, 2026 ET

Frequently asked questions

What does a Class I mean?

A situation in which there is a reasonable probability that use of or exposure to a product will cause serious adverse health consequences or death.

Is this recall still active?

According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.

What should I do if I have this product?

Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.

Where can I find more official information?

The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.

This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.

• Email
• X / Twitter
• Facebook